CEPHALON INC CEPH (NASDAQ) $ 61.61 Change: -2.59 -4.2% | Volume: 2,246,042
Sponsored by Click here!

CEPHALON INC - Fundamental Profile

Company Information

Ticker Symbol: CEPH
Exchange: NASD
Contact Info: 41 Moores Road Frazer PA 19355 610 344-0200
CEO/President: Frank Baldino Jr.
Industry: Medical - Biomedical / Standard Industry Code: 2834
Description: Cephalon is an international biopharmaceutical company focused on thediscovery, development and marketing of products to treat sleep disorders,neurological disorders, cancer and pain. In addition to an active research and development program, they market products in the United States and various countries in Europe.

Share Information

Shares Outstanding: 67,740 (000) Market Value: 4,500,340 ($000)
Percentage of Inst.Shareholders: 14.22% Number of Inst.Shareholders: 3.70%
Last Quarter Sales: 492.71 ($Mil.) Last Quarter Net Income: 60.07 ($Mil.)
Last Quarter EPS: 1.13 P/E Ratio: 17
Most Recent Earnings: 1.12 on 05/01/08 Earnings Per Share: -2.00
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN +14.00 58.89
GILEAD SCIENCES -0.20 45.75
GENENTECH INC +16.10 87.53
CELGENE CP -14.40 60.46
BIOGEN IDEC INC -16.30 50.50